When was PCI founded?

PCI was founded in 1997 and raised its 1st funding round 15 years after it was founded.

Where is PCI located?

PCI is headquartered in Philadelphia, United States.

How many employees does PCI have?

As of Sep 30, 2026, the latest employee count at PCI is 4998.

Is PCI a funded company?

PCI is a funded company, having raised an undisclosed amount across 4 funding rounds to date. The company's 1st funding round was a $***** PE round, raised on 2012.

How much is PCI worth?

The latest valuation of PCI is $***** as of Jul 14, 2025.

When was the latest funding round of PCI?

PCI's latest funding was a $***** PE round on Jul 14, 2025, with participation from 4 investors. Its primary sector is Biopharma Outsourcing. In United States, the Biopharma Outsourcing sector has seen $1.39B in funding in 2026 to date.

Where does PCI rank among its competitors?

PCI ranks 18th amongst 420 active competitors, of which 15 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was PCI, which secured an undisclosed amount in Jul, 2025.

Who are the top competitors of PCI?

PCI's top competitors include Concord Biotech, Biophore and Indoco Remedies. Among them, PCI secured the most recent funding round in July, 2025.

PCI - 2026 Company Profile, Team, Funding & Competitors

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 14, 2025	1656843	PE	2199825	2363335	6010305	8120342
2016	3490	PE	8875	1190	5337	5609
May 2013	7337689	Conventional Debt	8904398	6409494	8462583	8078727

PCI's employee count trend

PCI has 4,998 employees as of Sep 26. Here is PCI's employee count trend over the years:

Uncover PCI's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PCI include Concord Biotech, Biophore and Indoco Remedies. Here is the list of Top 10 competitors of PCI, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Concord Biotech 1984, Ahmedabad (India), Public	CDMO focused on manufacturing API	$11.3M	Quadria Capital, Helix Investments & 18 others	63/100
2nd	Biophore 2007, Hyderabad (India), Seed	Development and manufacturing of niche pharmaceutical products for the generic industry	$2.74M	Ontario & 6 others	62/100
3rd	Indoco Remedies 1947, Mumbai (India), Public	Provider of APIs manufacturing and formulation services	-	Baring Private Equity Partners	60/100
4th	Almac Group 2001, Craigavon (United Kingdom), Series D	CRAMS company offering preclinical development and CDMO services, also offering companion diagnostic development	$339M	Genomic Health, Gates & 4 others	59/100
5th	Wanbury Limited 1990, Mumbai (India), Public	Manufacturer of anti-diabetic drugs	-	-	56/100
6th	Jagsonpal 1964, Delhi (India), Public	Traditional company manufacturing bulk drugs and finished formulations	-	Convergent, Aresko	55/100
7th	Galenicum 2003, Barcelona (Spain), Late Stage	Turnkey solutions for drug development, manufacturing and regulatory approvals	-	Peninsula Capital	55/100
8th	Asymchem 1995, Morrisville (United States), Public	CDMO providing comprehensive pharmaceutical development and manufacturing solutions globally	-	Hillhouse, CoStone Capital & 5 others	53/100
9th	Amino 1958, Frellstedt (Germany), Unfunded	CDMO focused on amino acids and small molecules	-	-	52/100
10th	Aarti Drugs 1984, Mumbai (India), Public	APIs, intermediates and domestic formulations manufacturer	-	-	52/100
18th	PCI 1997, Philadelphia (United States), Late Stage	Provider of clinical & commercial supply chain and packaging solutions	-	Mubadala, Bain Capital & 7 others	50/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on PCI's competitors? Click here to see the top ones

PCI has not made any investments yet. PCI has made 11 acquisitions.

Here is the list of latest three $acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Apr 24, 2025	Acquisition	Ajinomoto Bio-Pharma	2018	San Diego (United States)
Oct 12, 2021	Acquisition	Lyophilization Services of New England	1997	Manchester (United States)
Feb 11, 2020	Acquisition	Bellwyckpharmaservices	2007	Burlington (Canada)